Analysis: 46% of Belgian single family offices are venture capital investors [2024]

Analysis: 46% of single family offices in Belgium invest in Venture Capital

We created this article as part of our research process for our European single-family office database. Here, we are investigating the share of Belgian single-family offices investing in startups and venture capital funds.

In total, 15 single-family offices in Belgium have a Venture Capital Focus. This represents a share of 46%.

Venture Capital (VC) investments play a crucial role in the economic landscape of Belgium, providing financial backing for start-ups and early-stage companies with high growth potential. Venture capital firms, investment banks, and other financial institutions – like single-family offices – typically make these investments. Belgium has seen a significant increase in VC activity over the past few years. The sectors attracting the most VC investments in Belgium include biotech and health tech, driven by the country’s strong research infrastructure and expertise in life sciences. Other sectors, such as fintech, software development, and e-commerce, have also seen substantial investment.

Most Belgian single-family offices that invest in startups are based in Brussels. As the capital city of Belgium and the administrative heart of the European Union, Brussels is a prime location for venture capital investments. The city boasts a vibrant start-up ecosystem, strong governmental support for businesses, and a multicultural and multilingual workforce. Additionally, its central location in Europe makes it an ideal hub for companies looking to expand into other European markets.

Belgian family office with venture capital focus: Korys

One exemplary Belgian family office that is an active startup backer is Korys, the investment vehicle of the Colruyt family. The family office focuses on three main verticals: Conscious Consumer, Energy Transition and Healthy Living. Portfolio companie include AguSurgical, a French robostics startup, Agendia, a biotech firm developing diagnostic cancer tets, or Ampacimon, which is investing power grid monitoring systems. Besides that, Korys is also investing in private equity funds like Acton, Alantra, Emerald or Cathay Capital.

You might also like the list of the largest biotech venture capital investors in the world, provided by our partner portal ThousandInvetors.

Picture source: Stephanie Leblanc

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *